Open Label Prostate Cancer Study

Clinical Trial ID NCT01162395

Rank	Title	Journal	Year	PubWeight™‹?›
1	New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway.	Clin Cancer Res	2011	2.01
2	Androgen receptor antagonists in castration-resistant prostate cancer.	Cancer J	2013	1.19
3	Targeting the androgen receptor in the management of castration-resistant prostate cancer: rationale, progress, and future directions.	Curr Oncol	2012	0.89
4	Targeting the androgen receptor in prostate and breast cancer: several new agents in development.	Endocr Relat Cancer	2015	0.89
5	Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.	BMC Cancer	2014	0.81
6	Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer.	Int J Biol Sci	2016	0.81
7	New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer.	Prostate Cancer	2011	0.79
8	Precision medicine for advanced prostate cancer.	Curr Opin Urol	2016	0.76
9	Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.	BMC Cancer	2016	0.75